| VRSN |
Report |
Q2 revenue |
IN-LINE |
pred ~$438.8m vs. cons $437.3m. |
MEDIUM |
| VRSN |
Report |
Q2 diluted EPS |
IN-LINE |
pred ~$2.48 vs. cons $2.46. |
MEDIUM |
| VRSN |
Report |
.com/.net net domain additions |
BEAT |
pred ~1.45m vs. cons 1.20m. |
MEDIUM |
| VRSN |
Guide |
FY2026 revenue guidance |
BETTER |
guide ~$1.743bn midpoint vs. cons $1.741bn (FY2026). |
MEDIUM |
| VRSN |
Guide |
FY2026 operating-income guidance |
BETTER |
guide ~$1.185bn midpoint vs. cons $1.183bn (FY2026). |
MEDIUM |
| VRSN |
Guide |
FY2026 .com/.net domain-base-growth guidance |
BETTER |
guide ~4.0% midpoint vs. cons 3.8% (FY2026). |
MEDIUM |
| VRSN |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.5% |
— |
MEDIUM |
| VRSN |
Return |
5-day cumulative residual |
+5.0% (FOLLOW-THROUGH) |
Net adds of ~1.45m versus 1.20m consensus and FY2026 revenue-guide midpoint of ~$1.743bn versus $1.741bn support upward 2026–2027 revenue and EPS revisions, rather than a one-day headline-EPS reaction. |
MEDIUM |